Nykode
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
Business Model:
Revenue: $0
Employees: 51-500
Rankings
Industries / Tags:
Detailed Nykode Information
Geographic Data
Address:
City: Oslo
State: Oslo
Zip:
Country: Norway
Financial Info
Stage:
series unknown
Raised Last:
$25M
Raised Total:$36M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops technology for novel vaccines and immunotherapy against HPV-induced malignancies.
Contact Phone:
Contact Email:
Nykode went public on 6/16/2022 on the OSE
Listed Exchange:
OSE
IPO Date:
6/16/2022
Ticker Symbol:
NYKD
IPO Price:
$3.11127213895945/share
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2014 | Venture Round | 1 | $6.9M |
Kreftforeningen Kreftforeningen Kreftforeningen Kreftforeningen |
6/2013 | Seed Round | 1 | $963.7k |
Norwegian Research Council Norwegian Research Council |
10/2012 | Grant | 1 | $2.6M |
Norwegian Research Council Norwegian Research Council |
12/2016 | Venture Round | 2 | $25M |
Norwegian Research Council Kreftforeningen Norwegian Research Council Kreftforeningen |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
